Link Back to CURRENT NEWS.

---

November 18, 2009: Translating Our Knowledge of Family History into Public Health Action - STRECH

The month's keynote speaker for the Seminar for Translational Research (STRECH) is Dr. Roldolfo Valdez, Epidemiologist, Centers for Disease Control and Prevention, Atlanta. The seminar starts at 4:00 PM until 5:00 PM and held at the UTHSCSA campus Academic Administration Bldg (AAB) 110.

The Seminars in Translational Research (STRECH) is a collaborative project between the University of Texas Health Science Center at San Antonio’s (UTHSCSA) Institute for Integration of Medicine and Science (IIMS) / Novel Clinical and Translational Methodologies and the University of Texas at San Antonio’s (UTSA) Department of Biomedical Engineering (BME) and the Research Centers in Minority Institutions (RCMI).

Seminars will be held the third Wednesday of each month from 4:00-5:00 PM, alternating between the UTSA and UTHSCSA campuses.
[ Read More about STRECH ]

May 13, 2010: Palmaz Scientific awarded $3 Million in ETF Funding

SAN ANTONIO--(BUSINESS WIRE)-- Texas House Speaker Joe Straus and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $3 million in Palmaz Scientific, Inc. through the Texas Emerging Technology Fund (ETF).
[ Read More ]

May 3-6, 2010: BIO International Conference

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

Visit us at BOOTH 4544: South Texas Technology Management is actively setting up appointments to meet with companies and potential licensees to discuss technologies available for licensing. Contact Richard Rodriguez at STTM to schedule an appointment with a licensing associate.

Dynamic coverage via Twitter hashtags: #bio2010 #bio1x1 #bioex
[ Event Details]

STTM Awards $50,000 to UT Researchers for Proof of Concept Grants

SAN ANTONIO (February 5, 2010) — South Texas Technology Management (STTM), the regional technology transfer office that serves four University of Texas institutions — UT Health Science Center at San Antonio (UTHSCSA), UT San Antonio (UTSA), UT Brownsville (UTB), and UT Pan American (UTPA), — today announced two new award recipients of the Proof of Concept: Short Proposals to Accelerate Research Commercialization (POCsparc) Grant Program.
[ Read More ]

STTM Tech Forum Presentations Available for Download

A PDF version of the Powerpoint presentations delivered by the featured panelists during the STTM 2010 Annual Tech Forum are now available for download.
[ Tech Forum Presentations ]

Dr. Luis V. Colom Named Vice President for Research at UTB/TSC

Dr. Luis V. Colom has been named the first vice president for Research for The University of Texas at Brownsville and Texas Southmost College.

[ Read More ]

January 14, 2010 - SAVE THE DATE: STTM 2010 Annual Tech Forum

"Collaborative Technology Commercialization" is the theme of STTM's 2010 Annual Tech Forum. This outreach event will showcase the collaborative roles and responsibilities of the universities in local and state technology-based economic development. Academic and industrial researchers, small business leaders and start-up entrepreneurs, state and local government officials, business service providers, investors, and others interested in regional technology transfer and economic development are expected to attend.
[ Event Details ]

September 17, 2009: Organ Preservation Device Expected to Save Lives.

San Antonio-based medical innovations company licenses technology developed at UT Health Science Center

SAN ANTONIO (Sept. 17, 2009) — The University of Texas Health Science Center at San Antonio today announced a license agreement with MCD Life Sciences LLC to commercialize a novel organ preservation technology. The technology, developed through more than a decade of scientific investigations in the School of Medicine, is expected to significantly increase the time that can elapse between removal of donor organs and their transplant into waiting recipients. The current four- to six-hour window could be expanded to as long as a day, the inventors said.
[ Read Full Press Release ]
[ KENS5 TV Report, Click for Video ]

September 16, 2009: STTM Participates in Seminar for Translational Research and Collaborative Funding

SAN ANTONIO (September 16, 2009) – STTM participated in the inaugural seminar series for Translational Research and Collaborative Funding Opportunities.

The Seminars in Translational Research (STRECH) is a collaborative project between the University of Texas Health Science Center at San Antonio’s (UTHSCSA) Institute for Integration of Medicine and Science (IIMS) / Novel Clinical and Translational Methodologies and the University of Texas at San Antonio’s (UTSA) Department of Biomedical Engineering (BME) and the Research Centers in Minority Institutions (RCMI).

Seminars will be held the third Wednesday of each month from 4:00-5:00 PM, alternating between the UTSA and UTHSCSA campuses.
[ Read More about STRECH ]

August 17, 2009: STTM Offers Support for Texas Ignition Fund Proposals.

South Texas Technology Management (STTM), the regional technology transfer office that serves four University of Texas institutions — the UT Health Science Center at San Antonio (UTHSCSA), UT San Antonio (UTSA), UT Brownsville (UTB), and UT Pan American (UTPA) — today announced that it is offering support and assistance to UT researchers interested in submitting Texas Ignition Fund (TIF) grant proposals.
[ Read More ]

June, 2009: Webinar Course on Researcher Commercialization

This online webinar course is recommended for researchers in research institutions (e.g., grad students, post-docs, professional staff and faculty) and researchers in commercial companies (e.g., startups, SBIRs, research-based small businesses and Global 1000). It allows attendees to make an informed decision as to how to better plan their commercialization efforts, be it through employment, licensing, consulting, joint venturing or startup creation.
[ Learn More ]

San Antonio Shines Its Light at BIO International Convention

BioMed SA, San Antonio, TX - May 27, 2009

San Antonio bioscience representatives showcased the Alamo City’s growing reputation as a “City of Science and Health” at last week’s BIO International Convention in Atlanta. The world’s largest biotechnology meeting drew more than 14,000 life science industry professionals, researchers, investors, and suppliers from 58 countries and 48 states.
[ Read More ]

April 27, 2009: UTSA, Health Science Center Collaborate with Merck & Co., Inc., to Develop Chlamydia Vaccine

San Antonio TX -- The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (Health Science Center) today announced an exclusive license and sponsored research agreement with Merck & Co., Inc., to develop a vaccine for chlamydia, targeting the common sexually transmitted bacterium Chlamydia trachomatis. [ Read Full Press Release ]

February 4, 2009: UT Health Science Center San Antonio, UTSA, UT Browsville, UT Pan American faculty teams receive $109,000 in technology transfer grants.

South Texas Technology Management (STTM), the regional technology transfer office that serves four University of Texas institutions — UT Brownsville (UTB), UT Pan American (UTPA), UT San Antonio (UTSA) and the UT Health Science Center at San Antonio — today announced five new award recipients of the Proof of Concept: Short Proposals to Accelerate Commercialization Grant Program. [ Press Release ] [ Grant Recipients ]

Dec. 17, 2008: Researchers have new way to treat strokes

Good news in the fight against a killer: stroke. San Antonio researchers have come up with a new way to treat strokes that may lead to some major changes. [ read more ]

Dec. 3, 2008: Discovery could help develop new treatments for depression

Some San Antonio scientists have made an important discovery that could help in the development of new treatments for depression. They’ve pinpointed a potential new target in the brain, using mice as a model. [ read more ]